ACE-031 vs Epithalon + Follistatin Stack

Overview

ACE-031 and Epithalon + Follistatin Stack are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares ACE-031 and Epithalon + Follistatin Stack across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. ACE-031 is categorised under Performance & Growth, while Epithalon + Follistatin Stack falls under Performance & Growth. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. ACE-031: not FDA-approved; treated as a research compound. Epithalon + Follistatin Stack: not FDA-approved; compounding permitted with a prescription as of April 2026.

Dosing. ACE-031 is typically dosed at Research only (research). Epithalon + Follistatin Stack is typically dosed at Protocol varies (cycled).

Can you stack them?

Some protocols combine peptides, but stacking ACE-031 and Epithalon + Follistatin Stack has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between ACE-031 and Epithalon + Follistatin Stack?

ACE-031 and Epithalon + Follistatin Stack are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status. ACE-031 is not FDA-approved; generally classified as a research compound, whereas Epithalon + Follistatin Stack is not FDA-approved; compounding permitted with a prescription (as of April 2026).

What is ACE-031 used for?

Myostatin inhibitor.

What is Epithalon + Follistatin Stack used for?

Anti-aging performance combo.

Can you take ACE-031 and Epithalon + Follistatin Stack together?

Some users combine peptides within a single protocol, but stacking ACE-031 and Epithalon + Follistatin Stack has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is ACE-031 or Epithalon + Follistatin Stack FDA-approved?

ACE-031 is not FDA-approved; generally classified as a research compound. Epithalon + Follistatin Stack is not FDA-approved; compounding permitted with a prescription (as of April 2026).